You are here

Breast Imaging

 

A third of breast-cancer patients undergoing preoperative mammography and ultrasound would be more accurately imaged for tumor size with breast MRI, according to a study published online April 13 in the Journal of Surgical Oncology. 

When women are recalled from screening mammography for additional imaging, they may soon be as likely to get scanned with automated ultrasound as with handheld, for European researchers have found similar performance between the two. 

Reinterpretation of community breast studies by a specialized cancer center yielded a change in interpretation in some 28 percent of studies submitted for a second opinion during a four-month period, according to findings published online March 16 in the American Journal of Roentgenology.

The mammography screening debates have been raging ever since 2009, when the U.S. Preventive Services Task Force began recommending that most women get screened every other year rather than every year and start their screenings at 50 rather than 40. A new study shows that, among women routinely participating in mammography screening, the recommendation has not lengthened the average interval between exam dates. 

Via Radiology, based in Seattle, is the first in the Pacific Northwest to offer a new type of MRI screening for breast cancer patients.

 

Recent Headlines

‘Controversial’ preoperative breast MRI more accurate than mammography/ultrasound for many patients

A third of breast-cancer patients undergoing preoperative mammography and ultrasound would be more accurately imaged for tumor size with breast MRI, according to a study published online April 13 in the Journal of Surgical Oncology. 

Automated breast ultrasound performs comparably to handheld

When women are recalled from screening mammography for additional imaging, they may soon be as likely to get scanned with automated ultrasound as with handheld, for European researchers have found similar performance between the two. 

Cancer-center rads show the value of re-reading community breast exams

Reinterpretation of community breast studies by a specialized cancer center yielded a change in interpretation in some 28 percent of studies submitted for a second opinion during a four-month period, according to findings published online March 16 in the American Journal of Roentgenology.

Mercy Medical System first in New York to install clinical LumaGEM MBI system

Gamma Medica announced that New York’s first clinical LumaGEM Molecular Breast Imaging (MBI) system has been installed at Mercy Center, a member of Catholic Health Services of Long Island.

Biennial breast-screening recommendation hasn’t moved the interval needle

The mammography screening debates have been raging ever since 2009, when the U.S. Preventive Services Task Force began recommending that most women get screened every other year rather than every year and start their screenings at 50 rather than 40. A new study shows that, among women routinely participating in mammography screening, the recommendation has not lengthened the average interval between exam dates. 

Affordable breast MRI protocol improving detection in women with dense breasts

Via Radiology, based in Seattle, is the first in the Pacific Northwest to offer a new type of MRI screening for breast cancer patients.

Government-run insurance marketplaces often fail to help women choose appropriate plans

Women seeking information about which plans cover which breast-health services in Affordable Care Act (ACA) marketplaces have been getting a lot of underinformed advice from customer-service reps. As a result, more than a few women have likely been buying plans that won’t meet their needs. 

Contralateral breast cancer a risk for women with dense tissue

Compared with breast-cancer patients who have nondense tissue, those with dense tissue are at significantly elevated risk of developing a tumor in the opposite breast. 

Breast imaging research team calls for raising the acceptable recall rate

Breast imaging practices that have screening recall rates of at least 12 percent but less than 14 percent are in the “sweet spot” for optimal detection of breast cancer. Practices that call back more than 14 percent of screening patients see little incremental benefit, while those that come in under 10 percent risk missing many cancers. 

Danish study challenges value of screening mammography, draws sharp criticism from U.S. orgs

European researchers have reviewed a huge mammography dataset and found no association between screening mammography and a reduction in the incidence of advanced breast cancer. 

Pages